BlackRock’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.96M Sell
3,491,136
-453,698
-12% -$1.03M ﹤0.01% 3481
2025
Q1
$6.11M Sell
3,944,834
-183,116
-4% -$284K ﹤0.01% 3516
2024
Q4
$9.7M Sell
4,127,950
-297,796
-7% -$700K ﹤0.01% 3401
2024
Q3
$16.1M Sell
4,425,746
-10,356
-0.2% -$37.6K ﹤0.01% 3132
2024
Q2
$15.4M Buy
4,436,102
+380,182
+9% +$1.32M ﹤0.01% 3086
2024
Q1
$25.9M Buy
4,055,920
+2,700,581
+199% +$17.2M ﹤0.01% 2783
2023
Q4
$8.73M Buy
1,355,339
+588,242
+77% +$3.79M ﹤0.01% 3395
2023
Q3
$1.79M Sell
767,097
-103,897
-12% -$242K ﹤0.01% 3974
2023
Q2
$2.07M Sell
870,994
-14,503
-2% -$34.5K ﹤0.01% 3960
2023
Q1
$1.63M Buy
885,497
+473,247
+115% +$871K ﹤0.01% 4064
2022
Q4
$783K Sell
412,250
-34,605
-8% -$65.8K ﹤0.01% 4408
2022
Q3
$956K Sell
446,855
-20,991
-4% -$44.9K ﹤0.01% 4403
2022
Q2
$1.33M Buy
467,846
+81,132
+21% +$230K ﹤0.01% 4333
2022
Q1
$1.61M Sell
386,714
-85,019
-18% -$354K ﹤0.01% 4389
2021
Q4
$2.45M Buy
471,733
+321,761
+215% +$1.67M ﹤0.01% 4257
2021
Q3
$983K Buy
149,972
+95,131
+173% +$624K ﹤0.01% 4499
2021
Q2
$364K Sell
54,841
-242,764
-82% -$1.61M ﹤0.01% 4701
2021
Q1
$1.71M Sell
297,605
-2,655
-0.9% -$15.2K ﹤0.01% 4270
2020
Q4
$2.68M Sell
300,260
-25,830
-8% -$231K ﹤0.01% 3868
2020
Q3
$3.8M Sell
326,090
-23,956
-7% -$279K ﹤0.01% 3598
2020
Q2
$5.61M Buy
350,046
+123,179
+54% +$1.97M ﹤0.01% 3404
2020
Q1
$1.36M Sell
226,867
-15,643
-6% -$93.7K ﹤0.01% 3705
2019
Q4
$3.2M Sell
242,510
-16,214
-6% -$214K ﹤0.01% 3581
2019
Q3
$3.21M Buy
258,724
+57,852
+29% +$718K ﹤0.01% 3563
2019
Q2
$3.23M Buy
200,872
+11,802
+6% +$190K ﹤0.01% 3592
2019
Q1
$5.95M Sell
189,070
-13,903
-7% -$438K ﹤0.01% 3316
2018
Q4
$6.67M Buy
202,973
+198,036
+4,011% +$6.5M ﹤0.01% 3270
2018
Q3
$151K Hold
4,937
﹤0.01% 4315
2018
Q2
$132K Buy
+4,937
New +$132K ﹤0.01% 4351